NCT03958175

Brief Summary

Reading disorders in Parkinson's Disease (PD) are poorly evaluated due to the lack of validated tests to screen for them. They are often attributed to hand tremors associated with the disease. In this study, the investigating team evaluated the "alouette test" validated for dyslexia screening, in PD by comparing the results to healthy patients.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
38

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Nov 2015

Shorter than P25 for all trials

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2015

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2016

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2016

Completed
3.1 years until next milestone

First Submitted

Initial submission to the registry

May 20, 2019

Completed
1 day until next milestone

First Posted

Study publicly available on registry

May 21, 2019

Completed
Last Updated

May 21, 2019

Status Verified

May 1, 2019

Enrollment Period

5 months

First QC Date

May 20, 2019

Last Update Submit

May 20, 2019

Conditions

Parkinson Disease

Outcome Measures

Primary Outcomes (1)

  • Score on the Alouette test

    The Alouette test is based on the precision and speed in reading a short text (279 words). The score corresponds to the total number of words correctly read.

    1 day

Study Arms (2)

Patients with Parkinson's Disease

Patients with Parkinson's Disease (PD) were evaluated for reading disorders using a screening method validated for dyslexia.

Other: Alouette test (reading test)

Patients without Parkinson's Disease = control group

Patients without Parkinson's Disease (PD) were evaluated for reading disorders using a screening method validated for dyslexia.

Other: Alouette test (reading test)

Interventions

Alouette test (reading test)OTHER

The alouette test was assessed at a fixed distance of 40 centimeters on a fixed surface to avoid errors related to hand tremors.

Patients with Parkinson's DiseasePatients without Parkinson's Disease = control group

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients who had Parkinson's Disease

You may qualify if:

  • Patients with Parkinson's Disease
  • Montreal Cognitive Assessment (MoCA) test \> 20

You may not qualify if:

  • Patient's with supranuclear Palsy
  • Other neurologic disease
  • Any ophthalmologic disease
  • Presence of a nystagmus
  • Visual acuity \< 0.6

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Parkinson Disease

Condition Hierarchy (Ancestors)

Parkinsonian DisordersBasal Ganglia DiseasesBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesMovement DisordersSynucleinopathiesNeurodegenerative Diseases

Study Officials

  • Thibaud Mathis, Dr

    Hospices Civils de Lyon

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 20, 2019

First Posted

May 21, 2019

Study Start

November 1, 2015

Primary Completion

April 1, 2016

Study Completion

April 1, 2016

Last Updated

May 21, 2019

Record last verified: 2019-05